A case of atezolizumab-induced photodistributed bullous pemphigoid.
bullous pemphigoid
immunotherapy
isophototopic response
Journal
Dermatologic therapy
ISSN: 1529-8019
Titre abrégé: Dermatol Ther
Pays: United States
ID NLM: 9700070
Informations de publication
Date de publication:
07 2019
07 2019
Historique:
received:
03
04
2019
accepted:
05
04
2019
pubmed:
13
4
2019
medline:
25
2
2020
entrez:
13
4
2019
Statut:
ppublish
Résumé
Immunotherapy has revolutionized cancer therapy in recent years but is associated with unique immunologically mediated adverse effects. Immunotherapy-induced bullous pemphigoid (BP) is an uncommon but established reaction that portends significant management implications as in most instances systemic treatment is required. We report a case of immunotherapy-associated BP in a marked photodistribution, highlighting the diverse clinical presentations of this eruption.
Substances chimiques
Antibodies, Monoclonal, Humanized
0
Antineoplastic Agents
0
atezolizumab
52CMI0WC3Y
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e12924Informations de copyright
© 2019 Wiley Periodicals, Inc.